AnxA3 silencing using miR382, which was accompanied by phosphoinositide-3-kinase/(PI3K)/protein kinase B (Akt) downregulation, reduced EMT and lymph node metastasis of pancreatic cancer cells [207]. The gene discussed is AKT1; the disease is pancreatic neoplasm.